GSK Warns Of HIV Drug's Heart Attack Risk

Law360, New York (December 3, 2009, 5:22 PM EST) -- GlaxoSmithKline PLC has issued a warning to health care professionals about a possible link between HIV medication Lexiva and heart attacks, changing the drug's prescription information to highlight that increases in cholesterol have occurred in conjunction with treatment.

GSK modified the warning and precautions section of Lexiva's prescribing information to add a recommendation that triglyceride and cholesterol testing be done on patients who use Lexiva, and that cholesterol testing should be done on patients both before they start taking Lexiva and periodically during their use of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.